Optimization of Anti-Thymocyte Globulin Administration Schedule in Reduced Intensity Conditioning for Allogeneic Hematopoietic Stem Cell Transplantation

被引：0
|
作者：
Simmons, Gary Lee [1 ]
Ribeiro, Anatevka [1 ]
Sabo, Roy [2 ]
Hawks, Kelly G. [1 ]
Aziz, May [3 ]
Wiedl, Christina M. [4 ]
Clark, William B. [1 ]
Chung, Harold M. [1 ]
McCarty, John M. [1 ]
Roberts, Catherine H. [1 ]
Toor, Amir A. [5 ]
机构：
[1] VCU Massey Canc Ctr, Bone Marrow Transplant, Richmond, VA USA
[2] Virginia Commonwealth Univ, Biostat, Richmond, VA USA
[3] Virginia Commonwealth Univ, Pharm, Richmond, VA USA
[4] Virginia Commonwealth Univ, Pediat Bone Marrow Transplant, Richmond, VA USA
[5] VCU Massey Canc Ctr, Bone Marrow Transplant Program, Dept Internal Med, Richmond, VA USA
来源：
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION | 2018年 / 24卷 / 03期
关键词：
D O I：
10.1016/j.bbmt.2017.12.393
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
481
引用
收藏
页码：S333 / S334
页数：2
相关论文
共 50 条
  • [21] Allogeneic haematopoietic stem cell translantation following reduced-intensity conditioning in patients with haematological malingancies: what is the role of anti-thymocyte globulin (ATG)?
    Batsis, I.
    Baliakas, P.
    Voutiadou, G.
    Mallouri, D.
    Kaloyannidis, P.
    Yannaki, E.
    Papathanasiou, M.
    Apostolou, D.
    Vardi, A.
    Apostolou, C.
    Sakellari, I.
    Anagnostopoulos, A.
    Papanikolaou, G.
    BONE MARROW TRANSPLANTATION, 2012, 47 : S415 - S415
  • [22] IMMUNE RECONSTITUTION FOLLOWING REDUCED INTENSITY CONDITIONING WITH CAMPATH-1H VERSUS TOTAL LYMPHOID IRRADIATION/ANTI-THYMOCYTE GLOBULIN PRIOR TO ALLOGENEIC STEM CELL TRANSPLANTATION
    Glotzbecker, B.
    Mills, H.
    Rosenblatt, J.
    Wu, Z.
    Wellenstein, K.
    Vasir, B.
    Joyce, R.
    Levine, J.
    Tzachanis, D.
    Zwicker, J.
    Boussiotis, V.
    Stevenson, M. A.
    Spitzer, T.
    Delaney, C.
    Bonhoff, J.
    Giallombardo, N.
    Conway, K.
    McDermott, D.
    Avigan, D.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2010, 16 (02) : S219 - S220
  • [23] Therapeutic Drug Monitoring of Anti-Thymocyte Globulin in Allogeneic Stem Cell Transplantation: Proof of Concept
    Meesters-Ensing, J. I.
    Admiraal, R.
    Ebskamp, L.
    Lacna, A.
    Boelens, J. J.
    Lindemans, C. A.
    Nierkens, S.
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [24] Allogeneic stem cell transplantation in a patient with dyskeratosis congenita after conditioning with low-dose cyclophosphamide and anti-thymocyte globulin
    Ayas, M.
    Al-Musa, A.
    Al-Jefri, A.
    Al-Seraihi, A.
    Al-Mahr, M.
    Rifai, S.
    El-Solh, H.
    PEDIATRIC BLOOD & CANCER, 2007, 49 (01) : 103 - 104
  • [25] Anti-thymocyte globulin-induced hyperbilirubinemia in patients with myelofibrosis undergoing allogeneic hematopoietic cell transplantation
    Ecsedi, Matyas
    Schmohl, Joerg
    Zeiser, Robert
    Drexler, Beatrice
    Halter, Jorg
    Medinger, Michael
    Duyster, Justus
    Kanz, Lothar
    Passweg, Jakob
    Finke, Juergen
    Bethge, Wolfgang
    Lengerke, Claudia
    ANNALS OF HEMATOLOGY, 2016, 95 (10) : 1627 - 1636
  • [26] Does antithymocyte globulin have a place in reduced-intensity conditioning for allogeneic hematopoietic stem cell transplantation?
    Siddiqi, Tanya
    Blaise, Didier
    HEMATOLOGY-AMERICAN SOCIETY HEMATOLOGY EDUCATION PROGRAM, 2012, : 246 - 250
  • [27] Anti-thymocyte globulin-induced hyperbilirubinemia in patients with myelofibrosis undergoing allogeneic hematopoietic cell transplantation
    Matyas Ecsedi
    Jörg Schmohl
    Robert Zeiser
    Beatrice Drexler
    Jörg Halter
    Michael Medinger
    Justus Duyster
    Lothar Kanz
    Jakob Passweg
    Jürgen Finke
    Wolfgang Bethge
    Claudia Lengerke
    Annals of Hematology, 2016, 95 : 1627 - 1636
  • [28] Comparison of Two Doses of Antithymocyte Globulin in Reduced-Intensity Conditioning Allogeneic Hematopoietic Stem Cell Transplantation
    Issa, Hassan
    Sharma, Nidhi
    Zhao, Qiuhong
    Ruppert, Amy S.
    Elder, Patrick
    Benson, Don M.
    Penza, Sam
    Vasu, Sumithira
    William, Basem
    Jaglowski, Samantha
    Devine, Steven M.
    Efebera, Yvonne A.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2019, 25 (10) : 1993 - 2001
  • [29] Does anti-thymocyte globulin have a place in busulfan/fludarabine conditioning for matched related donor hematopoietic stem cell transplantation?
    Ji, Young Sok
    Lee, Min Sung
    Min, Chang Wook
    Park, Seong Kyu
    Kim, Se Hyung
    Yun, Jina
    Kim, Hyun Jung
    Kim, Kyoung Ha
    Kim, Chan Kyu
    Lee, Kyu-Taek
    Won, Jong-Ho
    Hong, Dae Sik
    KOREAN JOURNAL OF INTERNAL MEDICINE, 2016, 31 (04): : 750 - 761
  • [30] ANTI-THYMOCYTE GLOBULIN (ATG) COULD IMPROVE THE OUTCOME OF ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION IN PATIENTS WITH AGGRESSIVE T CELL TUMORS
    Chun, W.
    Shike, Y.
    Liping, W.
    Jieling, J.
    Yu, C.
    Jun, Y.
    BONE MARROW TRANSPLANTATION, 2014, 49 : S105 - S105
12345